tirzepatide overdose symptoms GLP-1 overdoses have been skyrocketing, with poison centers seeing a nearly 1500% increase in calls related to or side effects of injectable weight-loss drugs since 2019, according to US National Poison Tirzepatide Overdose Risks: Safe Dosing

For many individuals, this becomes the maintenance dose, balancing substantial efficacy against manageable side effects

It is important to recall that tirzepatide for weight loss is not yet approved and this table assumes that the cost of tirzepatide for weight loss will be the same as the cost for diabetes though this may not be as in the case of semaglutide

The GLP1R rs6923761 variant, for example, influences GLP-1 receptor density and signaling efficiency, meaning some individuals achieve robust appetite suppression at lower semaglutide doses while others require higher doses for comparable effect

Known Risks, Side Effects, and Safety Considerations The most common side effects are gastrointestinal including nausea, vomiting, and diarrhoea with additional class-related risks of pancreatitis and gallbladder disease

GLP-1 receptor agonists and high blood pressure often coexist in people with type 2 diabetes, raising important questions about safety and treatment benefits